#USA #Orlando #ZEISS #ophthalmology #DORC

ZEISS Enhances DORC Portfolio and Digital Footprint at AAO 2025

ZEISS Medical Technology is making waves in the ophthalmic industry with its latest innovations set to be showcased at the American Academy of Ophthalmology (AAO) conference from October 18 to 20, 2025, in Orlando, Florida. This year, the focus is on improved workflow efficiency and enhanced digital visualization techniques across various ophthalmic applications.

Revolutionary 510k Clearance and Pathology Detection

Among the highlights will be the new 510k clearance for the optical coherence tomography angiography (OCT-A) with the ZEISS CIRRUS AngioPlex. This innovative technology offers non-invasive imaging capabilities of both retinal and choroidal vasculature, improving decision-making for eye care professionals. Additionally, the CLARUS® 700 will be presented, featuring fluorescein angiography (FA) and indocyanine green angiography (ICGA) to enable simultaneous capture, which supports more informed diagnostics.

Enhancing Surgical Experience for Retina Surgeons

ZEISS is also announcing significant updates to the DORC instrument lineup. These updates include new gauges for subretinal injection cannulae and the introduction of the Midfield endoillumination light probe. The light probe is designed with directed light to provide superior illumination, allowing surgeons to differentiate between various media during procedures. Notably, the updated CALLISTO eye® software for the ZEISS ARTEVO 750 and ARTEVO 850 offers enhanced visualization of retinal structures, elevating the surgery experience.

Optimizing Glaucoma Management in Cataract Patients

In addition to surgical tools, ZEISS will display integrated solutions for managing patients with both cataracts and glaucoma. This approach is crucial as glaucoma is a frequent comorbidity in cataract surgeries. The comprehensive workflow enables healthcare providers to make confident, data-driven decisions for effective treatment plans.

Next-Generation Research and Collaboration Tools

At AAO 2025, ZEISS will unveil its AI-ready Research Data Platform (RDP), aimed at empowering retina specialists to conduct impactful research and translate clinical hypotheses into measurable results. The platform optimizes data management, integrating seamlessly with existing electronic medical records (EMR) systems for enhanced collaboration and analysis across the eye care community.

Furthermore, the new browser-based digital data management solution showcases ZEISS's commitment to modernizing clinical operations. By aggregating critical medical data and offering real-time insights, healthcare professionals can streamline their workflows significantly.

Celebrating Milestones in Refractive Surgery

During the event, ZEISS will also celebrate its success in refractive surgery, noting that over 12 million eyes have been treated with ZEISS SMILE and SMILE pro technologies. The company continues to advance these renowned solutions, showcasing their proven effectiveness and reliability among surgeons.

The company's demonstration at AAO 2025 is a clear testament to ZEISS’s ongoing dedication to innovation. “We are committed to advancing our clinical workflows, making them more efficient and enabling doctors globally to provide personalized healthcare experiences,” said Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology. This sentiment resonates through the numerous technological enhancements being introduced, reinforcing ZEISS's role as a leader in ophthalmic technology.

ZEISS invites all attendees to visit booth #2261 at AAO 2025 to experience the company's innovative solutions firsthand, further illustrating its mission to transform ophthalmology for better patient outcomes.

For more information regarding ZEISS's latest innovations, please refer to zeiss.com/med.